Abstract
The progress that has been made in the global response to AIDS is real — but inadequate. An estimated 1 million people throughout the world are now using antiretroviral medications for human immunodeficiency virus (HIV) infection — double the number who were receiving such treatment two years ago. As of June 2004, 440,000 people from low- and middle-income countries were being treated.1 About 125,000 were from sub-Saharan Africa, where the burden is the greatest, an increase of 100,000 in two years. Spending on AIDS in low- and middle-income countries has increased from $1.0 billion in 2000 to $3.9 billion in . . .

This publication has 1 reference indexed in Scilit: